Laura Korin, Doctor of the Haematology Service and Unit Of Haematopoietic Transplantation (UTH) of the Alexander Fleming Institute, shared a post on X:
“Long term outcomes of FL.
15y frorm diagnosis 60% of patients receiving ICT in 1L did not require 2L (curable disease?). And for all of us who favor observation in low tumor burden 1/3 of patients remain treatment free at 15y.”
More updates from ASH25 on OncoDaily.
